First humans test new mystery pill in early safety trial
NCT ID NCT07222709
Summary
This is the first time researchers are testing a new oral drug called ABBV-1042 in people. The study aims to check if the drug is safe and how the body processes it in 48 healthy adult volunteers. Participants will receive either the drug or a placebo, and doctors will monitor them closely for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Acpru /Id# 279405
RECRUITINGGrayslake, Illinois, 60030, United States
Conditions
Explore the condition pages connected to this study.